_sarclisa-isatuximab-update-124-paul-richardson-md-124-ims-2022-preview-1.jpg "SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022 from isatuximab uk Video Screenshot Preview 1")
Gallery_sarclisa-isatuximab-update-124-paul-richardson-md-124-ims-2022-preview-3.jpg "SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022 from isatuximab uk Video Screenshot Preview 3")
Gallery_sarclisa-isatuximab-update-124-paul-richardson-md-124-ims-2022-preview-hqdefault.jpg "SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022 from isatuximab uk Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 59 seconds
👁 View: 261 times
Play Audio:👁 View: 261 times
Description:
HealthTree Foundation for Multiple Myeloma
HealthTree Foundation for Multiple Myeloma
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_what-is-isatuximab-and-how-does-it-compare-with-daratumumab.webp "International Myeloma Foundation")
_all-about-sarclisa-isatuximab.webp "HealthTree University Myeloma")
_safety-amp-efficacy-of-isatuximab-pomalidomide-and-dexamethasone-in-frail-patients-with-r-r-myeloma.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 50 seconds 👁 28
_real-world-safety-amp-efficacy-of-isatuximab-pomalidomide-dexamethasone-in-r-r-multiple-myeloma.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 45 seconds 👁 38
_the-role-of-isatuximab-in-the-management-of-mm.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_asco-2019-isatuximab-icaria-mm-trial-updates-with-dr-paul-richardson.webp "HealthTree Foundation for Multiple Myeloma")
_daratumumab-and-isatuximab-in-the-treatment-of-multiple-myeloma.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_multiple-myeloma-in-2023-what-patients-amp-caregivers-need-to-know-now-124-the-patient-story.webp "The Patient Story")
⏲ 31 minutes 15 seconds 👁 16.4K
_what-is-isatuximab-and-how-does-it-compare-with-daratumumab.jpg)
_all-about-sarclisa-isatuximab.jpg)
_safety-amp-efficacy-of-isatuximab-pomalidomide-and-dexamethasone-in-frail-patients-with-r-r-myeloma.jpg)
_real-world-safety-amp-efficacy-of-isatuximab-pomalidomide-dexamethasone-in-r-r-multiple-myeloma.jpg)
_the-role-of-isatuximab-in-the-management-of-mm.jpg)
_asco-2019-isatuximab-icaria-mm-trial-updates-with-dr-paul-richardson.jpg)
_daratumumab-and-isatuximab-in-the-treatment-of-multiple-myeloma.jpg)
_multiple-myeloma-in-2023-what-patients-amp-caregivers-need-to-know-now-124-the-patient-story.jpg)
![[+]](/images/menu.gif){kind=small}